1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. TREVI THERAPEUTICS INC
Trevi Therapeutics Inc XNAS: TRVI

Trevi Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary f...

Read More
11.94 0.18 (1.53%)
146.19% Gain from 52W Low
779.3K
XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Trevi Therapeutics Inc is on 18 Mar 2026 for the purpose of Trevi Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
3.2 / 100
Momentum Score
Technically Moderately Bullish
67.0 / 100
Analyst Price Target
No estimates available

10

S

6

W

6

O

0

T

SWOT Analysis

Trevi Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..